Amgen Earnings
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$5.70
Amgen earnings summary
Amgen is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $5.70. In its most recent report on Aug 5, 2026 (Q2 2026), AMGN posted EPS of $4.37. Revenue for the quarter was $10.05 billion.
Quarterly EPS is up 64.9% from the same quarter a year earlier. Across the last 16 reports, AMGN shares moved an average of 2.6% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
AMGN earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $4.37 | — | +1.0% |
| May 1, 2026 | — | $3.34 | — | +0.6% |
| Feb 13, 2026 | — | $2.45 | — | +1.5% |
| Nov 5, 2025 | — | $5.93 | — | +5.2% |
| Aug 6, 2025 | — | $2.65 | — | +2.9% |
| May 2, 2025 | — | $3.20 | — | -5.5% |
| Feb 14, 2025 | — | $1.17 | — | +4.1% |
| Oct 31, 2024 | — | $5.22 | — | +1.9% |
| Aug 7, 2024 | — | $1.38 | — | -0.3% |
| May 3, 2024 | — | $-0.21 | — | -0.4% |
| Feb 14, 2024 | — | $1.42 | — | +1.9% |
| Oct 31, 2023 | — | $3.22 | — | -0.9% |
| Aug 4, 2023 | — | $2.57 | — | +7.9% |
| Apr 28, 2023 | — | $5.28 | — | -1.3% |
| Feb 9, 2023 | — | $3.00 | — | -0.8% |
| Nov 4, 2022 | — | $3.98 | — | +5.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.